asciminib tablets

asciminib tablets
for oral use Initial U.S. Approval: 2021

Scemblix (asciminib) is a prescription medication used to treat adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).

Facts about asciminib tablets

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Novartis
USAGE-Film-coated tablets: 20 mg and 40 mg
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “asciminib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

asparaginase erwinia chrysanthemi injection

Leukemia, Lymphoma

asparaginase erwinia chrysanthemi (recombinant) rywn) injection, for intramuscular use Initial U.S. Approval: 2021

Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) is a prescription medicine that is a component of a multi-agent chemotherapeutic regimen used to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adults and children aged 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase.

Facts about asparaginase erwinia chrysanthemi injection

Disease Indications-Leukemia, Lymphoma
Manufacturer-Jazz Pharmaceuticals
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “asparaginase erwinia chrysanthemi injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

azacitidine injection

Leukemia

azacitidine for injection
for SC or IV use Initial U.S. Approval: 2004

As specified in the prescribing information, azacitidine injection is indicated for the treatment of Leukemia. Onureg (azacitidine) is a medication used for the continued treatment of adults with acute myeloid leukemia (AML).

Facts about azacitidine injection

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Celgene
USAGE-Oral
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “azacitidine injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Blinatumomab for injection

Leukemia

blinatumomab for injection
for intravenous use Initial U.S. Approval: 2014

blinatumomab is a bispecific CD19-directed CD3 T-cell engager indicated for the treatment of adults and children with: • B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%.

Facts about Blinatumomab for injection

Approval Date: 2014
Proprietary Name: On Request
Active Ingredient(s): Blinatumomab for injection
Dosage Forms And Strengths: For injection: 35 mcg of lyophilized powder in a single-dose vial for reconstitution.
Manufacturer: Amgen Inc
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Blinatumomab for injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

bosutinib tablets

Leukemia

bosutinib tablets
for oral use Initial U.S. Approval: XXXX

Bosulif (bosutinib) is a medication used for the treatment of chronic myeloid leukaemia (CML) in adults with the Philadelphia chromosome (Ph+). It is used to treat adult patients with newly-diagnosed chronic phase Ph+ chronic myelogenous leukemia (CML) or with chronic, accelerated, or blast phase Ph+ CML with resistance or intolerance to prior therapy.

Facts about bosutinib-tablets

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Pfizer Limited
USAGE-Tablets: 100 mg and 500 mg
MEDICINE APPROVED BY-European Medical Agency (EMA),Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “sotorasib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

calaspargase pegol-mknl injection

Leukemia

calaspargase pegol -mknl injection
for intravenous use Initial U.S. Approval: 2018

Asparlas (calaspargase pegol-mknl) is a component of a multiagent chemotherapeutic regimen for the treatment of Acute Lymphoblastic Leukemia (ALL) in pediatric and young adult patients aged 1 month to 21 years.

Facts about calaspargase pegol -mknl injection

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Servier
USAGE-Intravenous
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “sotorasib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Dasatinib Tablets

Leukemia

dasatinib Tablet
for Oral Use Initial U.S. Approval: 2006

SPRYCEL is a kinase inhibitor indicated for the treatment of • newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

Facts about Dasatinib Tablets

Approval Date: 2006
Proprietary Name: On Request
Active Ingredient(s): Dasatinib Tablets
Dosage Forms And Strengths: Tablets: 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.
Company: Bristol-Myers Squibb
Current indications: chronic Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML)
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Dasatinib Tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Daunorubicin and cytarabine liposome injection

Leukemia

Daunorubicin and cytarabine liposome injection
for subcutaneous use Initial U.S. Approval: 2017

Daunorubicin and cytarabine is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, a nucleoside metabolic inhibitor, that is indicated for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).

Facts about Daunorubicin and cytarabine liposome injection

Approval Date: 2017
Proprietary Name: On Request
Active Ingredient(s): Daunorubicin and cytarabine liposome injection
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Daunorubicin and cytarabine liposome injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

decitabine and cedazuridine tablets

Leukemia

decitabine and cedazuridine tablets,
for oral use Initial U.S. Approval: 2020

Inqovi (decitabine and cedazuridine) is a medication used for the treatment of adults with myelodysplastic syndromes (MDS), including chronic myelomonocytic leukemia (CMML).

Facts about decitabine and cedazuridine tablets

Disease Indications-Leukemia
Manufacturer-Astex Pharmaceuticals
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA), Health Canada
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “decitabine and cedazuridine tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

duvelisib capsules

Leukemia, Lymphoma

duvelisib capsules
for oral use Initial U.S. Approval: 2018

Copiktra (duvelisib) is a medication used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and follicular lymphoma (FL) after at least two prior therapies.

Facts about duvelisib capsules

Disease Indications-Leukemia, Lymphoma
Manufacturer-Verastem Inc.
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “duvelisib capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

List of Oncology Medication For

Leukemia

Indian Pharma Network

M: +9891296838 / 9811747774E: med@indianpharmanetwork.co.in

asciminib tablets for oral use Initial U.S. Approval: 2021

Facts about asciminib tablets

Access the best support services globally

asparaginase erwinia chrysanthemi (recombinant) rywn) injection, for intramuscular use Initial U.S. Approval: 2021

Facts about asparaginase erwinia chrysanthemi injection

Access the best support services globally

azacitidine for injection for SC or IV use Initial U.S. Approval: 2004

Facts about azacitidine injection

Access the best support services globally

blinatumomab for injection for intravenous use Initial U.S. Approval: 2014

Facts about Blinatumomab for injection

Access the best support services globally

bosutinib tablets for oral use Initial U.S. Approval: XXXX

Facts about bosutinib-tablets

Access the best support services globally

calaspargase pegol -mknl injection for intravenous use Initial U.S. Approval: 2018

Facts about calaspargase pegol -mknl injection

Access the best support services globally

dasatinib Tablet for Oral Use Initial U.S. Approval: 2006

Facts about Dasatinib Tablets

Access the best support services globally

Daunorubicin and cytarabine liposome injection for subcutaneous use Initial U.S. Approval: 2017

Facts about Daunorubicin and cytarabine liposome injection

Access the best support services globally

decitabine and cedazuridine tablets, for oral use Initial U.S. Approval: 2020

Access the best support services globally

duvelisib capsules for oral use Initial U.S. Approval: 2018

Facts about duvelisib capsules

Access the best support services globally

Contact Info

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

M: +9891296838 / 9811747774
E: med@indianpharmanetwork.co.in

asciminib tablets
for oral use Initial U.S. Approval: 2021

azacitidine for injection
for SC or IV use Initial U.S. Approval: 2004

blinatumomab for injection
for intravenous use Initial U.S. Approval: 2014

bosutinib tablets
for oral use Initial U.S. Approval: XXXX

calaspargase pegol -mknl injection
for intravenous use Initial U.S. Approval: 2018

dasatinib Tablet
for Oral Use Initial U.S. Approval: 2006

Daunorubicin and cytarabine liposome injection
for subcutaneous use Initial U.S. Approval: 2017

decitabine and cedazuridine tablets,
for oral use Initial U.S. Approval: 2020

duvelisib capsules
for oral use Initial U.S. Approval: 2018